Singapore markets closed
Straits Times Index
3,212.64 -6.36 (-0.20%) Nikkei
27,385.25 -34.36 (-0.13%) Hang Seng
19,915.68 -133.96 (-0.67%) FTSE 100
7,358.39 -141.21 (-1.88%) Bitcoin USD
28,052.08 +345.57 (+1.25%) CMC Crypto 200
611.63 +14.17 (+2.37%)
Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 77.81 |
| Open | 77.78 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 900 |
| Day's range | 77.65 - 78.93 |
| 52-week range | 57.17 - 89.74 |
| Volume | |
| Avg. volume | 6,194,930 |
| Market cap | 98.222B |
| Beta (5Y monthly) | 0.40 |
| PE ratio (TTM) | 21.82 |
| EPS (TTM) | 3.61 |
| Earnings date | 26 Apr 2023 - 01 May 2023 |
| Forward dividend & yield | 3.00 (3.78%) |
| Ex-dividend date | 14 Mar 2023 |
| 1y target est | 88.96 |
- Zacks
Biotech Stock Roundup: ALT Obesity Data, GILD Exercises Option, INCY Drug Approval
Incyte's (INCY) skin cancer drug approval and Altimmune's obesity data are the key highlights from the biotech sector during the past week.
- Zacks
Gilead Sciences (GILD) Dips More Than Broader Markets: What You Should Know
Gilead Sciences (GILD) closed at $77.81 in the latest trading session, marking a -1.68% move from the prior day.
- Zacks
Gilead (GILD) Announces OS Data on Yescarta From ZUMA-7 Study
Gileads Yescarta shows statistically significant improvement in overall survival for initial treatment of R/R LBCL patients versus historical standard of care in curative setting.
© 2023 Yahoo. All rights reserved.
